ACADIA Pharmaceuticals
ACAD
#3663
Rank
C$4.14 B
Marketcap
$24.93
Share price
0.40%
Change (1 day)
-35.80%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): C$0.18 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are C$0.92 Billion. In 2023 the company made an earning of -C$73.09 Million, an increase over its 2022 earnings that were of -C$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$0.18 B-352.37%
2023 -C$73.09 Million-76.09%
2022 -C$0.31 Billion27.41%
2021 -C$0.24 Billion-40.38%
2020 -C$0.41 Billion19.88%
2019 -C$0.34 Billion-3.92%
2018 -C$0.35 Billion-15.04%
2017 -C$0.42 Billion6.33%
2016 -C$0.39 Billion64.55%
2015 -C$0.24 Billion77.47%
2014 -C$0.14 Billion143.69%
2013 -C$54.35 Million81.93%
2012 -C$29.87 Million-8.73%
2011 -C$32.73 Million-251.39%
2010 C$21.61 M-133.2%
2009 -C$65.12 Million-30.82%
2008 -C$94.12 Million6.43%
2007 -C$88.44 Million25.89%
2006 -C$70.25 Million36.99%
2005 -C$51.28 Million37.22%
2004 -C$37.37 Million19.96%
2003 -C$31.15 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$53.67 Million-127.42%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.94 B 4,979.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.53 B 7,325.76%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.34 B 13,357.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$9.86 Billion-5,133.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$55.32 Million-128.26%๐Ÿ‡บ๐Ÿ‡ธ USA